GEUSENS, Piet

Full Name
GEUSENS, Piet
Email
piet.geusens@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 281-300 of 451 (Search time: 0.006 seconds).

Issue DateTitleContributor(s)TypeCat.
2812005Newer drug treatments: Their effects on fracture preventionGEUSENS, Piet; Reid, DJournal ContributionA1
2822005Characteristics and performance of an immunosorbent assay for human matrix Gla-proteinSCHURGERS, Jo; Teunissen, KJF; Knapen, MHJ; GEUSENS, Piet; VAN DER HEIJDE, Desiree; Kwaijtaal, M; van Diest, R; Ketteler, M; Vermeer, CJournal ContributionA1
2832005Hip and nonspine fracture risk reductions differ among antiresorptive agents. Evidence from randomized controlled trials.Liberman, UA; Hochberg, MC; Chattopadhyay, A; Ross, PD; GEUSENS, PietJournal ContributionM
2842005Peripheral blood but not synovial fluid natural killer T cells are biased towards a Th1-like phenotype in rheumatoid arthritisLINSEN, Loes; THEWISSEN, Marielle; BAETEN, Kurt; SOMERS, Veerle; GEUSENS, Piet; RAUS, Jef; STINISSEN, PietJournal ContributionA1
2852005Osteoporosis and fall risk in patients with fragility fracturesvan Helden, SH; Nieuwenhuijzen-Kruseman, AC; Dinant, G; Pijpers, E; ten Broeke, R; Brink, PR; GEUSENS, PietJournal ContributionM
2862005Synovial fluid NKT cells display different properties compared to peripheral blood NKT cells in rheumatoid arthritisLINSEN, Loes; SOMERS, Veerle; THEWISSEN, Marielle; GEUSENS, Piet; RAUS, Jef; STINISSEN, PietJournal ContributionM
2872005A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoidsvan Staa, TP; GEUSENS, Piet; Pols, HAP; de Laet, C; Leufkens, HGM; Cooper, CJournal ContributionA1
2882005Cost-effectiveness analysis of Aclasta in Paget's disease of bone in BelgiumLecomte, P; Devogelaer, JP; Kaufman, JM; Goemaere, S; Engbersen, A; GEUSENS, PietJournal ContributionM
2892004Performance of the OST risk tool for identifying men at risk of osteoporosisGEUSENS, Piet; Hochberg, MC; Adler, Robert A.Journal ContributionM
3502004Efficacy, safety and tolerability of lumiracoxib in patients with rheumatoid arthritisGEUSENS, Piet; Alten, R.; Rovensky, J; Sloan, VS; Krammer, G; Kralidis, G; Richardson, PJournal ContributionA1
3512004Efficacy and safety of four doses of lumiracoxib versus diclofenac in patients with knee or hip primary osteoarthritis: A phase II, four-week, multicenter, randomized, double-blind, placebo-controlled trialSchnitzer, TJ; Beier, J.; GEUSENS, Piet; Hasler, P; Patel, SK; Senftleber, I; Gitton, X; Moore, A.; Sloan, VS; Poor, GJournal ContributionA1
3522004The relationship between vertebral wedging in the thoracic spine and the occiput-to-wall-distance (OWD) in ankylosing spondylitis (AS) patientsVosse, D; Landewe, RBM; Van der Linden, S; GEUSENS, Piet; VAN DER HEIJDE, DesireeJournal ContributionM
3532004Osteoprotegerin and receptor activator of nuclear factor-kappa B ligand mRNA expression in patients with rheumatoid arthritis and healthy controlsVANDER BORGHT, Ann; LINSEN, Loes; THEWISSEN, Marielle; GEUSENS, Piet; RAUS, Jef; STINISSEN, PietJournal ContributionA1
3542004The estimation of the 5-year probability of fracture in a general population of elderly women.van Staa, TP; Leufkens, H; Gehlbach, S; Cooper, C; GEUSENS, PietJournal ContributionM
3552004Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a 24-week randomized, placebo-controlled trial (ASSERT)Dijkmans, B; Sieper, J; DeWoody, K; Williamson, R; Braun, J; VAN DER HEIJDE, Desiree; GEUSENS, PietJournal ContributionM
3562004Ankylosing spondylitis and the risk of fracture.Vosse, D; van der Linden, S; Cooper, C; van Staa, TP; GEUSENS, Piet; VAN DER HEIJDE, DesireeJournal ContributionM
3572004The cost-effectiveness of bone protection in patients using oral glucocorticoids.van Staa, TP; Leufkens, H; Pols, H; Cooper, C; GEUSENS, PietJournal ContributionM
3582004Musculoskeletal rehabilitation in osteoporosis: A reviewPfeifer, M; Sinaki, M; GEUSENS, Piet; Boonen, S; Preisinger, E; Minne, H.W.Journal ContributionA1
3592004Fracture incidence after fragility fractures admitted to the hospitalvan Helden, SH; Bulstra, S; Brink, PRG; Koeyers, W; GEUSENS, PietJournal ContributionM
3602004Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritisLandewe, R; GEUSENS, Piet; Boers, M; VAN DER HEIJDE, Desiree; Lems, W; Koppele, JT; van der Linden, S; Garnero, PJournal ContributionA1